http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004002447-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa48a431ce250933eb0fdd7a1caf3f30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
filingDate 2003-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ccf7dc6a0e089d64c4e5f015df9bb1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6f6db7a6e1b7008c1ea749a31a2eb18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc90cccf549cf6090745ff07ff4bcc99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_699957fc02f7410f4170c9d29608ad33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4db5e2aaa55c90ed7cc65bf0eb7a055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f43126abe968405d5a85781a35074469
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d66c95de58c013de34ed347ca12ea8b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4df2f8f1cc0da14e1d0ed97b8b27488a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baabd13cd8091c74507183070b50a890
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f072010fe239a2f88646bca0fc94b29e
publicationDate 2004-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004002447-A3
titleOfInvention Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton
abstract Dosage forms and devices for enhancing controlled delivery of pharmaceutical agents by use of a drug core composition containing a polymer carrier (e.g. polyethylene oxide) and a surfactant (e.g. polyoxyl stearate, poloxamer) that increases the solubility of the pharmaceutical agent are described. The present invention provides a means of delivering high doses of lowly soluble drug in oral drug delivery systems that are convenient to swallow, for once-a-day administration. Osmotic devices are described.
priorityDate 2002-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9963971-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9506460-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5906832-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0000179-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5082655-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0072841-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6294192-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507197
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284627
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579320
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033836

Total number of triples: 41.